English
Select your language
Official EU languages:
Access to European Union law
EUR-Lex
Access to European Union law
This document is an excerpt from the EUR-Lex website
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Need more search options? Use the
Advanced search
Document 62016TB0295
Case T-295/16
General Court
Status: Closed
General Court
Status: Closed
/
DECISION
- Complementary documents:
08/05/2017
- Title
- Auto del Tribunal General (Sala Segunda) de 7 de marzo de 2017. SymbioPharm GmbH contra Agencia Europea de Medicamentos. Recurso de anulación — Medicamentos de uso humano — Inicio del procedimiento de recurso ante la EMA — Artículos 31 a 34 de la Directiva 2001/83/CE — Medicamento Symbioflor 2 y medicamentos con designaciones similares — Acto no recurrible — Acto de trámite — Inadmisibilidad. Asunto T-295/16.
- ECLI identifier
- ECLI:EU:T:2017:147
- Applicant
- Particular
- Defendant
- Agencia Europea de Medicamentos, Instituciones y organismos de la UE
- Judge-Rapporteur
- Buttigieg
- Type of procedure
- Recurso de anulación - inadmisible
- Complementary documents:
07/03/2017
CASE BROUGHT
- Title
- Asunto T-295/16: Recurso interpuesto el 6 de junio de 2016 — SymbioPharm/EMA
01/08/2016